VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage

BACKGROUND: Vasoactive intestinal peptide (VIP) and pituitary adenylyl cyclase-activating polypeptide (PACAP) are two highly homologous neuropeptides. In vitro and ex vivo experiments repeatedly demonstrate that these peptides exert pronounced immunomodulatory (primarily anti-inflammatory) actions w...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Neuroinflammation
Päätekijät: Abad, Catalina, Jayaram, Bhavaani, Becquet, Laurine, Wang, Yuki, O’Dorisio, M Sue, Waschek, James A., Tan, Yossan-Var
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2016
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4928347/
https://ncbi.nlm.nih.gov/pubmed/27357191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-016-0626-3
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia